/ Not yet recruitingPhase 1IIT A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Eltrombopag 25 mg tablets relative to Revolade 25 mg tablets in healthy Thai volunteers under fasting condition.
/ Not yet recruitingPhase 1IIT A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Empagliflozin Film-Coated Tablets 25 mg relative to JARDIANCE (Empagliflozin Film-Coated Tablets 25 mg) in healthy Thai volunteers under fasting condition
/ Not yet recruitingPhase 1IIT A bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two treatment and two-sequence of Dienogest Tablet 2 mg relative to Visanne (original Dienogest Tablet 2 mg) in healthy Thai female volunteers under fasting condition
100 Clinical Results associated with Bio-innova Co., Ltd
0 Patents (Medical) associated with Bio-innova Co., Ltd
100 Deals associated with Bio-innova Co., Ltd
100 Translational Medicine associated with Bio-innova Co., Ltd